Chronic Myeloid Leukemia: A Historical PerspectiveGOLDMAN, John M.Seminars in hematology. 2010, Vol 47, Num 4, pp 302-311, issn 0037-1963, 10 p.Article

TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemiaNAKA, Kazuhito; HOSHII, Takayuki; MURAGUCHI, Teruyuki et al.Nature (London). 2010, Vol 463, Num 7281, pp 676-680, issn 0028-0836, 5 p.Article

Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression dataYEUNG, K. Y; GOOLEY, T. A; ZHANG, A et al.Bioinformatics (Oxford. Print). 2012, Vol 28, Num 6, pp 823-830, issn 1367-4803, 8 p.Article

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy?MAHON, François-Xavier; ETIENNE, Gabriel.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 310-322, issn 1078-0432, 13 p.Article

Quantitative modeling of chronic myeloid leukemia: insights from radiobiologyRADIVOYEVITCH, Tomas; HLATKY, Lynn; LANDAW, Julian et al.Blood. 2012, Vol 119, Num 19, pp 4363-4371, issn 0006-4971, 9 p.Article

First-line therapy for chronic myeloid leukemia : past, present, and futurePAVLOVSKY, Carolina; KANTARJIAN, Hagop; CORTES, Jorge E et al.American journal of hematology. 2009, Vol 84, Num 5, pp 287-293, issn 0361-8609, 7 p.Article

Patient With Chronic Myeloid Leukemia in Complete Cytogenetic Response: What Does It Mean, and What Does One Do Next?MARIN, David.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 379-384, issn 0732-183X, 6 p.Article

Advances in the Development of Animal Models of Myeloid LeukemiasGURYANOVA, Olga A; LEVINE, Ross L.Seminars in hematology. 2013, Vol 50, Num 2, pp 145-155, issn 0037-1963, 11 p.Article

Chronic myeloid leukemia: 2012 Update on diagnosis, monitoring, and managementJABBOUR, Elias; KANTARJIAN, Hagop.American journal of hematology. 2012, Vol 87, Num 11, pp 1038-1045, issn 0361-8609, 8 p.Article

HIF1α is required for survival maintenance of chronic myeloid leukemia stem cellsHAOJIAN ZHANG; HUAWEI LI; XI, Hualin S et al.Blood. 2012, Vol 119, Num 11, pp 2595-2607, issn 0006-4971, 13 p.Article

How I treat CML blast crisisHEHLMANN, Rüdiger.Blood. 2012, Vol 120, Num 4, pp 737-747, issn 0006-4971, 11 p.Article

Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemiaLU, J; MA, Y; KONG, N et al.Leukemia. 2011, Vol 25, Num 7, pp 1211-1213, issn 0887-6924, 3 p.Article

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemiaDONG HWAN KIM; LEE, Seung-Tae; SANG KYUN SOHN et al.Blood. 2011, Vol 117, Num 25, pp 6906-6911, issn 0006-4971, 6 p.Article

Chronic Myeloid Leukemia and Second-Generation Tyrosine Kinase Inhibitors: When, How, and Which One?JABBOUR, Elias; KANTARJIAN, Hagop; CORTES, Jorge et al.Seminars in hematology. 2010, Vol 47, Num 4, pp 344-353, issn 0037-1963, 10 p.Article

Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibilityKNIGHT, Jeffrey A; SKOL, Andrew D; LARSON, Richard A et al.Blood. 2009, Vol 113, Num 22, pp 5575-5582, issn 0006-4971, 8 p.Article

La leucémie myéloïde chronique chez le patient âgéREA, Delphine.Hématologie (Montrouge). 2012, Vol 18, pp 3-5, issn 1264-7527, 3 p., SUP2Article

Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBACCARANI, M; PILERI, S; STEEGMANN, J.-L et al.Annals of oncology. 2012, Vol 23, issn 0923-7534, vii72-vii77, SUP7Article

Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal responseROY, Lydia; TOMOWIAK, Cécile; GUILHOT, François et al.Blood. 2011, Vol 118, Num 19, pp 5096-5098, issn 0006-4971, 3 p.Article

A Multicellular Basis for the Origination of Blast Crisis in Chronic Myeloid LeukemiaSACHS, Rainer K; JOHNSSON, Kerstin; HAHNFELDT, Philip et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 8, pp 2838-2847, issn 0008-5472, 10 p.Article

Compte-rendu sur les hémopathies myéloïdes d'après le 16e congrès de l'EHA (European Hematology Association), 9-12 juin 2011, LondresKILADJIAN, Jean-Jacques.Correspondances en onco-hématologie. 2011, Vol 6, Num 3, issn 1954-4820, 18 p., SUP3Serial Issue

Chronic Myeloid Leukemia Stem CellsKAVALERCHIK, Edward; GOFF, Daniel; JAMIESON, Catriona H. M et al.Journal of clinical oncology. 2008, Vol 26, Num 17, pp 2911-2915, issn 0732-183X, 5 p.Article

Therapy-Related Myeloid LeukemiaGODLEY, Lucy A; LARSON, Richard A.Seminars in oncology. 2008, Vol 35, Num 4, pp 418-429, issn 0093-7754, 12 p.Article

Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemiaSIGNER, Robert A. J; MONTECINO -RODRIGUEZ, Encarnacion; WITTE, Owen N et al.Blood. 2007, Vol 110, Num 6, pp 1831-1839, issn 0006-4971, 9 p.Article

Construction and expression of humanized chimeric T cell receptor specific for chronic myeloid leukemia cellsDONG WANG; LIJUN ZHANG; YAJUAN LI et al.Biotechnology letters. 2012, Vol 34, Num 7, pp 1193-1201, issn 0141-5492, 9 p.Article

Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population studyCORM, Selim; ROCHE, Laurent; REMONTET, Laurent et al.Blood. 2011, Vol 118, Num 16, pp 4331-4337, issn 0006-4971, 7 p.Article